Pelthos Therapeutics Inc. PTHS Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $27.7M— | $16.8M— | $7.41M— | $0— | $0— | ||
| $5.66M— | $3.99M— | $2.32M— | $0— | $0— | ||
| $22.04M— | $12.81M— | $5.09M— | $0— | $0— | ||
| 79.6%— | 76.3%— | 68.7%— | —— | —— | ||
| $1.22M+34.5% | $1.23M+4.1% | $1.14M-64.3% | $1.41M-50.1% | $906.96K-68.3% | ||
| $61.92M— | $42.45M— | $25.52M— | $7.53M— | —— | ||
| —— | —— | —— | —— | $7.51M— | ||
| -$43.68M-485% | -$32.43M-328% | -$22.25M-131% | -$8.94M-0.8% | -$7.47M+5.2% | ||
| -157.7%— | -193.1%— | -300.4%— | —— | —— | ||
| $5.23M— | $3.01M— | $1.81M— | $499K— | —— | ||
| -$15.29M-13,944% | -$18.28M-4,661% | -$1.8M-306% | -$100.52K+89.1% | $110.47K+110% | ||
| -$58.98M-701% | -$50.71M-537% | -$24.05M-139% | -$9.04M+7.7% | -$7.36M+18.0% | ||
| -$7.39M— | -$7.39M— | -$465K— | $0— | $0— | ||
| -$51.59M-601% | -$43.32M-445% | -$23.58M-134% | -$9.04M+7.7% | -$7.36M+18.0% | ||
| -186.2%— | -257.9%— | -318.4%— | —— | —— | ||
| —— | —— | —— | —— | -$13.91-76.1% | ||
| -$40.29M-439% | -$30.53M-303% | -$21.57M— | -$8.94M— | -$7.47M— | ||
| -145.4%— | -181.8%— | -291.3%— | —— | —— | ||
| -$43.68M-485% | -$32.43M-328% | -$22.25M-131% | -$8.94M-0.8% | -$7.47M+5.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Pelthos Therapeutics Inc.'s revenue?
- Pelthos Therapeutics Inc. (PTHS) generated $27.7M in revenue over the trailing twelve months.
- Is Pelthos Therapeutics Inc. profitable?
- Pelthos Therapeutics Inc. is not currently profitable: it reported a net loss of $51.6M over the trailing twelve months, a -186.2% net margin.
- What are Pelthos Therapeutics Inc.'s profit margins?
- Gross margin is 79.6% and operating margin is -157.7%, with a -186.2% net margin.
- What is Pelthos Therapeutics Inc.'s earnings per share?
- Pelthos Therapeutics Inc.'s diluted EPS over the trailing twelve months is $-13.44.
- Where does Pelthos Therapeutics Inc.'s income statement data come from?
- Every line is extracted from Pelthos Therapeutics Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
